A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES)

NCT07717840 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV Respiratory Syncytial Virus

Interventions

BIOLOGICAL: AZD6489
BIOLOGICAL: Licensed RSV vaccine #1
BIOLOGICAL: Licensed RSV vaccine #2

Sponsor

AstraZeneca